Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | HOOK |
---|---|---|
09:32 ET | 1222 | 2.72 |
09:39 ET | 2908 | 2.69 |
09:42 ET | 100 | 2.69 |
09:55 ET | 222 | 2.695 |
10:04 ET | 5518 | 2.65 |
10:09 ET | 2314 | 2.64 |
10:11 ET | 380 | 2.67 |
10:13 ET | 1200 | 2.575 |
10:18 ET | 1000 | 2.5858 |
10:29 ET | 250 | 2.59 |
10:31 ET | 100 | 2.5749 |
10:47 ET | 300 | 2.57 |
10:56 ET | 100 | 2.58 |
11:07 ET | 149 | 2.5514 |
11:14 ET | 1500 | 2.54 |
11:16 ET | 300 | 2.55 |
11:21 ET | 100 | 2.517 |
11:25 ET | 292 | 2.5214 |
11:30 ET | 1700 | 2.47 |
11:32 ET | 3118 | 2.49 |
11:38 ET | 1000 | 2.49 |
11:39 ET | 706 | 2.5 |
11:43 ET | 4660 | 2.49 |
11:52 ET | 1020 | 2.45 |
11:54 ET | 1182 | 2.42 |
11:56 ET | 100 | 2.4802 |
11:57 ET | 3000 | 2.4999 |
11:59 ET | 6000 | 2.4201 |
12:03 ET | 758 | 2.5766 |
12:06 ET | 1407 | 2.5 |
12:10 ET | 122 | 2.52 |
12:15 ET | 700 | 2.6 |
12:17 ET | 15859 | 2.52 |
12:19 ET | 3691 | 2.49 |
12:24 ET | 3000 | 2.485 |
12:26 ET | 700 | 2.46 |
12:28 ET | 1234 | 2.4507 |
12:39 ET | 514 | 2.5192 |
12:44 ET | 492 | 2.47 |
12:46 ET | 300 | 2.4754 |
12:48 ET | 2251 | 2.46 |
12:57 ET | 1000 | 2.52 |
01:00 ET | 7529 | 2.44 |
01:02 ET | 1000 | 2.4835 |
01:04 ET | 1100 | 2.49 |
01:06 ET | 600 | 2.45 |
01:09 ET | 300 | 2.46 |
01:13 ET | 226 | 2.4872 |
01:18 ET | 250 | 2.488 |
01:22 ET | 100 | 2.4779 |
01:26 ET | 1146 | 2.5173 |
01:33 ET | 5976 | 2.4411 |
01:36 ET | 312 | 2.4693 |
01:45 ET | 100 | 2.46 |
01:47 ET | 315 | 2.5027 |
01:49 ET | 2493 | 2.45 |
01:54 ET | 200 | 2.45 |
02:02 ET | 299 | 2.4209 |
02:03 ET | 400 | 2.4 |
02:12 ET | 299 | 2.4 |
02:14 ET | 1750 | 2.4088 |
02:16 ET | 100 | 2.395 |
02:18 ET | 685 | 2.395 |
02:20 ET | 4732 | 2.36 |
02:21 ET | 2406 | 2.27 |
02:23 ET | 13234 | 2.32 |
02:25 ET | 1000 | 2.34 |
02:27 ET | 250 | 2.34 |
02:30 ET | 1200 | 2.3357 |
02:32 ET | 200 | 2.325 |
02:34 ET | 2843 | 2.325 |
02:41 ET | 1376 | 2.3566 |
02:45 ET | 164 | 2.33 |
02:48 ET | 130 | 2.3796 |
02:50 ET | 1116 | 2.35 |
02:56 ET | 1082 | 2.3 |
02:57 ET | 100 | 2.34 |
03:03 ET | 2800 | 2.345 |
03:06 ET | 233 | 2.3553 |
03:08 ET | 100 | 2.3451 |
03:10 ET | 150 | 2.33 |
03:12 ET | 1199 | 2.3299 |
03:14 ET | 207 | 2.32 |
03:15 ET | 1600 | 2.3407 |
03:17 ET | 448 | 2.354456 |
03:19 ET | 124 | 2.323 |
03:21 ET | 305 | 2.36 |
03:26 ET | 100 | 2.335 |
03:32 ET | 214 | 2.356 |
03:33 ET | 300 | 2.3201 |
03:35 ET | 400 | 2.34 |
03:39 ET | 300 | 2.35 |
03:44 ET | 612 | 2.35 |
03:51 ET | 700 | 2.34 |
03:53 ET | 4400 | 2.3 |
03:55 ET | 436 | 2.34 |
03:57 ET | 320 | 2.32 |
04:00 ET | 11911 | 2.3 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
HOOKIPA Pharma Inc | 27.7M | -0.6x | --- |
Cara Therapeutics Inc | 17.0M | -0.2x | --- |
Turnstone Biologics Corp | 10.9M | -0.1x | --- |
Viaderma Inc | 10.7M | 0.0x | --- |
SQZ Biotechnologies Co | 781.5K | 0.0x | --- |
Prenetics Global Ltd | 54.0M | -1.2x | --- |
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel immunotherapies, based on its proprietary arenavirus platform, which is designed to mobilize and amplify targeted T cells and thereby fight or prevent serious disease. The Company’s replicating and non-replicating technologies are engineered to induce durable antigen-specific CD8+ T cell responses and pathogen-neutralizing antibodies. Its oncology programs include HB-200 and HB-700, all of which use its replicating technology. HB-200 is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) cancers in a Phase I/II clinical trial. HB-700 is in preclinical development for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Its Hepatitis B (HBV) program, HB-400, and its Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in a partnership with Gilead Sciences, Inc.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $27.7M |
---|---|
Revenue (TTM) | $50.0M |
Shares Outstanding | 12.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.72 |
EPS | $-4.11 |
Book Value | $7.45 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -121.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.